Saw Palmetto for Prostate Health

Research suggests that saw palmetto and its primary active component, beta-sitosterol, show promising but inconsistent results for prostate health, with the available evidence drawing from a mix of in vitro cell studies, animal models, retrospective analyses, and narrative reviews rather than large-scale randomized controlled trials. Studies indicate that beta-sitosterol can inhibit prostate cancer cell growth in laboratory settings by activating tumor-suppressor pathways, and that certain saw palmetto extracts demonstrate measurable inhibition of 5-alpha-reductase, the enzyme linked to benign prostatic hyperplasia, with potency varying considerably depending on the extraction method used — a factor researchers have proposed may explain the inconsistent outcomes seen across clinical studies. For BPH-related urinary symptoms, reviews suggest beta-sitosterol offers meaningful but modest improvements compared to standard pharmaceutical treatments, and one 2019 review characterized the overall evidence for saw palmetto specifically as mixed, noting that other plant-based options such as Pygeum africanum and pollen extract showed comparably favorable results. A 2024 laboratory study introduced a note of caution by finding that beta-sitosterol may alter collagen distribution in prostate stromal cells in an age-dependent manner, which could theoretically be relevant given that the primary users of these supplements are older men, though the clinical significance of this finding remains unclear.